Rhenman & Partners Asset Management AB

Holdings History for MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Symbol
MLTX on Nasdaq
Investment type
Equity / Class A ordinary share, par value $0.0001 per share
Shares, Excluding Options vs Price
Value, Excluding Options
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.